# Accra-Pac, Inc. – FDA Inspection, Sep 2, 2022

Source: https://www.keypedia.com/records/fda_inspections/accra-pac-inc/88b44c01-a15d-4051-87e3-3848c5e76845
Source feed: FDA_Inspections

> FDA inspection 1178990 of Accra-Pac, Inc., September 02, 2022. Classification: Official Action Indicated (OAI). 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178990
- Company Name: Accra-Pac, Inc.
- Inspection Date: 2022-09-02
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1288190 - 2026-03-05](https://www.keypedia.com/records/fda_inspections/accra-pac-inc/bf4bc3ba-f0e2-46ed-94db-9b0405913265)
- FDA Inspection 1157187 - 2021-11-05
- [FDA Inspection 1009786 - 2017-04-05](https://www.keypedia.com/records/fda_inspections/accra-pac-inc/c717e591-2184-4717-8e3f-c943f688dfe8)
- [FDA Inspection 904407 - 2014-11-21](https://www.keypedia.com/records/fda_inspections/accra-pac-inc/9006c3b4-74be-4ad4-ac58-8d4a7ab590fa)
- FDA Inspection 855917 - 2013-11-20

Company: https://www.keypedia.com/companies/accra-pac-inc/fe89d000-bb66-4348-9b5a-2e86dd5117eb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
